耀才团队: 新旧经济股或再个别发展
耀才研究部称,隔晚(16日)美股续升,美国药厂莫德纳(Moderna)研发的新冠病毒疫苗在测试中有效性达到94.5%,而且疫苗容易储存及运送,刺激道指再度抽升,道指盘中曾高见29964点,旧经济股再度发力。港股ADR靠稳,汇控ADR升1.8%报39.51元,但腾讯、阿里ADR则高位回落,将限制恒指今早的表现,料指数今早将先行高开100点左近,创月内新高。京东(09618.HK)公布今年首9个月非通用会计准则(Non-GAAP)纯利144.41亿元人民币,按年升45.3%,绩後股价急挫,ADR亦下跌一成见330.5元,加上疫苗憧憬或再度令资金从新经济股流出,留意今日一众新经济股之表现。
从技术上看,恒指至今仍企稳26,000点关口,指数於上周五(13日)略为修补上周一遗留下的上升裂口後已马上回稳,可见恒指於26,000点关口有不俗的支持力度,目前短线阻力位在本月高位26,474点,而较关键的阻力位则在7月7日高位26,782点,只要恒指能继续企稳26,000点关口之上,目前实不宜胡乱看淡。
(笔者为证监会持牌人)~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.